Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FAKJX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,875
Award facts
- Contract value 100% obligated
- $38,875.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $38,875.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx Sensoready 300mg dose in 2-pen/ml format. The contract, effective January 7, 2026, with an ultimate completion date of January 8, 2026, represents a pharmaceutical supply delivery under a non-set-aside, competitively awarded procurement. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs.
Cosentyx (secukinumab) is a biologic immunosuppressant used to treat autoimmune conditions including psoriasis, ankylosing spondylitis, and psoriatic arthritis. The delivery order fulfills critical pharmaceutical needs for military treatment facilities and veterans' healthcare programs that rely on DLA's medical supply chain. As a major pharmaceutical distributor, Cencora/AmerisourceBergen has demonstrated capability to meet federal procurement requirements through its extensive portfolio of specialty medications, brand-name and generic drugs, and medical supplies delivered across multiple therapeutic domains to defense and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FAKJX?
SPE2DR26FAKJX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FAKJX worth?
The government has obligated $38,875 on SPE2DR26FAKJX.
Is contract SPE2DR26FAKJX an order under another contract?
Yes. SPE2DR26FAKJX is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKJX competed?
The extent of competition for SPE2DR26FAKJX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award